| 摘要 |
<p>Non-human mammalian cell lines which express the major human rhinovirus receptor protein. The cell lines are prepared by gene transfection of human DNA, such as HeLa cell DNA, into non-human mammalian cells, such as mouse cells. Primary transfectants can be transfected into further non-human mammalian cells to provide secondary transfectants. Cloning of secondary transfectants yields cell lines that exhibit enhanced expression of the surface receptor protein. The transfectant cell lines provide a means for cloning the major human rhinovirus receptor protein gene and immunogens for producing antibodies, particularly monoclonal antibodies, against the receptor protein. A general method for screening drug candidates for their ability to block ligand binding to a human cell surface receptor protein is also provided.</p> |
